A newapproach toChronicpain
Nuro Medical is developing a new, non-invasive approach to neuromodulation for chronic pain and related conditions.
20
Minute Sessions
3 X
Per Day
At Home
Treatment
In Development
Targeted
Stimulation
Neural
care
reimagined
Why Pain Persists
Central sensitisation and a body stuck in fight-or-flight
In conditions such as fibromyalgia, the nervous system can become sensitised, amplifying pain signals that would normally be less painful. This is known as central sensitisation. At the same time, autonomic imbalance may keep the body stuck in a prolonged fight-or-flight state.
01Central Sensitisation
Sensitised neural pathways can increase the intensity and persistence of pain signals.
02Fight-or-Flight
The body may struggle to shift out of sympathetic alert and into the calmer state needed for rest and recovery.
03Whole-Body Effects
Pain, disrupted sleep, fatigue, brain fog and emotional wellbeing can become interconnected.
Nuro Medical is developing a non-invasive neuromodulation approach designed to influence neural circuits involved in pain processing and autonomic regulation.
How Nuro Works
Designed to influence the circuits involved in pain
Nuro is developing a non-invasive neuromodulation device that delivers precisely patterned electrical stimulation through the skin to a novel neural target.
01Targeted Stimulation
Gentle electrical stimulation is delivered through skin-contacting electrodes to a novel neural target.
02Patterned Neural Signals
Proprietary stimulation patterns are designed to engage neural pathways involved in pain processing and autonomic function.
03Supporting Regulation
The aim is to help reduce central sensitisation and excessive sympathetic activity, supporting a shift away from persistent pain and fight-or-flight.
Nuro’s technology is currently in development and is not yet approved for commercial use. Clinical studies are being undertaken to evaluate its safety and effectiveness.
One Nervous System. Many Conditions.
Different diagnoses. Overlapping mechanisms.
Chronic pain can have many different causes, but some conditions may share underlying features such as central sensitisation and autonomic dysfunction. Nuro is investigating whether neuromodulation of these shared pathways could offer a new approach.
Fibromyalgia
Lead indication
Migraine
Neuropathic Pain & CRPS
Pelvic Pain & Endometriosis
Nuro’s initial clinical development is focused on fibromyalgia, with research also exploring other chronic pain conditions.
Early Observations
Encouraging patient-reported reductions in pain
In our early observational work, people living with a range of chronic pain conditions have reported reductions in pain while using Nuro’s investigational neuromodulation technology.
Average patient-reported reduction in pain
Fibromyalgia
Reduction in pain
n=12
Neuropathic Pain
Reduction in pain
n=9
Migraine
Reduction in pain
n=6
Endometriosis Pain
Reduction in pain
n=2
Benefits Reported Beyond Pain
Reduced anxiety and depression • Better sleep • Improved energy • Clearer thinking • Calmer fight-or-flight response
These are preliminary, patient-reported observations from an observational group of 22 people. Some participants experienced more than one condition and therefore appear in more than one condition group. These results are not from a controlled clinical trial.
Nuro is an investigational medical device and is not yet approved for commercial use. Safety and effectiveness have not yet been established through controlled clinical trials.
The People Behind Nuro
Built on decades of neuromodulation experience
Nuro Medical brings together medical-device development and neuroscience with a shared goal: developing a new non-invasive approach to persistent pain.
Dr Wade McFarlane, PhD
Co-founder & CEO
Biomedical engineer and medical-device executive with more than 20 years’ experience, including neuromodulation leadership roles with Medtronic, Abbott and Saluda Medical.
Professor Dirk De Ridder, MD, PhD
Co-founder & Chief Medical Officer
Neurosurgeon and internationally recognised neuromodulation researcher with more than 350 scientific publications and decades of experience researching neural mechanisms involved in pain and neuromodulation.
Stay Connected
Follow Nuro’s journey
Whether you’re living with persistent pain, working in healthcare or research, or following Nuro’s progress as a company, choose the updates that matter to you.